Loading
FORT MYERS — Retina Health Center Director Dr. Alexander Eaton and research colleagues were awarded a patent for a guarded injection device.
According to a press release, Dr. Eaton and his colleagues developed the device with the I-Tech JV Development Company to reduce infection risk during injections for retinal disorders. It's used for the targeted application of medication.
The device uses a small gauge needle covered by a thin protective sleeve designed to protect the needle from contamination risks, a statement says.
The Retina Health Center in Fort Myers conducted clinical trials with 70 patients in July 2012 to evaluate the device.
“The guarded injection device addresses an unmet need by providing a simple way of reducing injection times and theoretically reducing risk of injection from direct contact with eyelids, aerosolized saliva and other environmental contaminants during injection,” says Dr. Eaton in a statement.
Dr. Eaton founded the Retina Health Center and the Macular Degeneration Research Center in 2002.
Your free article limit has been reached this month.
Subscribe now for unlimited digital access to our award-winning business news.
Join thousands of executives who rely on us for insights spanning Tampa Bay to Naples.
